Transdermal buprenorphine patch-facilitated induction of sublingual buprenorphine in hospitalized patients receiving full agonist opioids: a retrospective cohort study
Transdermal buprenorphine-facilitated low dose buprenorphine initiation in hospitalized patients receiving full agonist opioids was well-tolerated in the majority of patients, with 7.4% (95% CI: 2.4-16.3%) developing precipitated withdrawal.
Authors
- Alek Adkins
- David A. Goldfarb (ORCID: https://orcid.org/0000-0003-0487-7187)
- David J. Barton (ORCID: https://orcid.org/0000-0003-0976-0383)
- Simon J. Ostrowski (ORCID: https://orcid.org/0000-0003-4574-4663)
- Anthony F. Pizon (ORCID: https://orcid.org/0000-0002-1196-6930)
- Darien Stratton
- Melissa Kukowski
Institutions
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Clinical Toxicology
- Published
- 2025-09-17
- DOI
- https://doi.org/10.1080/15563650.2025.2553811
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00